Sonic hedgehog and neurotrophin-3 increase oligodendrocyte numbers and myelination after spinal cord injury

Integr Biol (Camb), 2014 · DOI: 10.1039/c4ib00009a · Published: July 24, 2014

Spinal Cord Injury Regenerative Medicine Neurology

Simple Explanation

Spinal cord injuries (SCI) often lead to loss of motor and sensory functions, with limited treatment options available. The study explores using 'bridges' to support axon growth through the injury site. The research focuses on identifying the cell types responsible for myelinating these axons and investigates whether specific trophic factors, NT3 and SHH, can improve myelination. The experiment involves delivering NT3, SHH, or a combination of both using lentivirus-containing bridges implanted into a spinal cord injury in mice, and then observing how the body's own progenitor cells respond.

Study Duration

8 weeks

Participants

Mice (C57Bl6 females, 4-6 wks old, n = 4 per condition)

Evidence Level

Not specified

Key Findings

1
Sustained expression of NT3 and SHH significantly increased the growth of regenerating axons into the implanted bridge and enhanced their myelination after eight weeks.
2
SHH specifically decreased Sox2+ cells (neural lineage progenitors) and increased Olig2+ cells (oligodendrocyte lineage cells), while NT3, alone or combined with SHH, enhanced GFAP+ (astrocytes) and Olig2+ cells.
3
NT3 enhanced myelination primarily by recruiting Schwann cells, while SHH overexpression substantially increased myelination by oligodendrocytes.

Research Summary

This study investigates the potential of NT3 and SHH, delivered via biomaterial bridges, to enhance axon regeneration and myelination following spinal cord injury (SCI) in mice. The results demonstrate that localized and sustained expression of NT3 and SHH promotes axon growth and myelination, with SHH primarily stimulating oligodendrocyte-mediated myelination and NT3 enhancing Schwann cell recruitment. The study highlights the potential of combining biomaterials with gene delivery for targeted and long-term delivery of regenerative factors to promote spinal cord repair.

Practical Implications

Targeted Therapy Development

The findings support the development of targeted therapeutic strategies using localized delivery of growth factors to promote axon regeneration and myelination after SCI.

Combination Therapy

Combining SHH and NT3 may offer a synergistic approach to promote myelination by both oligodendrocytes and Schwann cells, maximizing the potential for functional recovery.

Biomaterial Design

The study provides insights into the design of biomaterial scaffolds that can effectively deliver therapeutic agents and modulate the local microenvironment to enhance tissue regeneration.

Study Limitations

1
The study was conducted in a mouse model, and the results may not be directly translatable to humans.
2
The analysis focused on histological investigation of endogenous progenitor cells and axonal processes.
3
The study did not assess functional outcomes, limiting the conclusions that can be drawn about the clinical relevance of the findings.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury